[Mechanism of delta-sleep inducing peptide geroprotective activity]
Discovery Date: 1973 GHK-Cu is not approved for human consumption, medical use, or therapeutic application
Gene expression studies reveal modulation of 408 neuronal genes, including dramatic increases in OPRM1 (opioid receptor, up 1,294%), KCND1 (up 845%), and SLC8A2 (up 737%)
Abstract The proper function of the brain is entirely dependent on intact neurotransmission, where glutamate (Glu) and -aminobutyric acid (GABA) are the two most present neurotransmitters
Using a topical serum is a great starting point, but professional peptide therapy offers a more comprehensive and targeted approach
IV therapy is generally safe and administered by our licensed nurses under medical oversight